Stock listing
NASDAQ:CERT Certara, Inc. Stock
Home listing (NASDAQ) of Certara, Inc.
Follow Certara, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:CERT
$10.55 USD -0.63 (-5.6%)
Close on Nov 20, 2026
- Day range
- $10.42 – $10.86 USDNov 20, 2026
- Volume
- 2.78M sharesNov 20, 2026
- Market cap
- $1.61B USDAt the close on Nov 20, 2026 · price × 152.5M shares outstanding
- 52-week range
- $4.45 – $12.61 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $25.32M USDMedian day 2.37M shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:CERT · Home | $10.55 USD | -0.63 (-5.6%) | 2,781,245 | $10.52 | $10.86 | $10.42 | $11.18 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:CERT · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $10.55 | -0.63 | -5.6% | $10.52 | $10.86 | $10.42 | 2,781,245 | |
| $11.18 | +0.12 | +1.1% | $11.02 | $11.35 | $11.00 | 1,745,127 | |
| $11.06 | -0.33 | -2.9% | $11.29 | $11.54 | $11.05 | 2,283,335 | |
| $11.39 | -0.18 | -1.6% | $11.35 | $11.46 | $11.15 | 2,841,014 | |
| $11.57 | -0.33 | -2.8% | $12.02 | $12.18 | $11.55 | 2,668,403 | |
| $11.90 | +0.17 | +1.4% | $11.73 | $11.97 | $11.29 | 3,121,258 | |
| $11.73 | -0.395 | -3.3% | $12.25 | $12.38 | $11.67 | 3,154,812 | |
| $12.13 | -0.095 | -0.8% | $12.00 | $12.27 | $11.85 | 2,879,893 | |
| $12.22 | +0.17 | +1.4% | $12.12 | $12.60 | $11.98 | 5,840,896 | |
| $12.05 | -0.13 | -1.1% | $12.03 | $12.61 | $11.79 | 4,871,017 | |
| $12.18 | +1.09 | +9.8% | $11.21 | $12.25 | $10.82 | 3,731,632 | |
| $11.09 | +0.22 | +2.0% | $11.08 | $11.28 | $10.78 | 2,424,144 | |
| $10.87 | +0.16 | +1.5% | $10.58 | $11.02 | $10.46 | 1,869,815 | |
| $10.71 | -0.31 | -2.8% | $11.08 | $11.09 | $10.65 | 1,951,624 | |
| $11.02 | -0.18 | -1.6% | $11.07 | $11.19 | $10.65 | 1,946,362 | |
| $11.20 | -0.28 | -2.4% | $11.37 | $11.56 | $11.08 | 2,727,208 | |
| $11.48 | +0.53 | +4.8% | $10.84 | $11.72 | $10.84 | 2,370,447 | |
| $10.95 | +0.34 | +3.2% | $10.50 | $10.98 | $10.44 | 2,416,785 | |
| $10.61 | +0.28 | +2.7% | $10.20 | $10.63 | $10.08 | 2,347,918 | |
| $10.33 | +0.24 | +2.4% | $9.95 | $10.37 | $9.835 | 2,058,145 | |
| $10.09 | -0.09 | -0.9% | $10.14 | $10.31 | $9.86 | 2,365,317 | |
| $10.18 | +0.395 | +4.0% | $9.67 | $10.29 | $9.47 | 1,717,477 | |
| $9.785 | +0.335 | +3.5% | $9.50 | $9.85 | $9.37 | 2,784,588 | |
| $9.45 | +0.08 | +0.9% | $9.37 | $9.50 | $9.255 | 1,504,652 | |
| $9.37 | -0.29 | -3.0% | $9.745 | $9.94 | $9.215 | 2,359,200 | |
| $9.66 | +0.30 | +3.2% | $9.39 | $9.701 | $9.25 | 1,658,200 | |
| $9.36 | -0.24 | -2.5% | $9.54 | $9.63 | $9.28 | 1,821,200 | |
| $9.60 | +0.36 | +3.9% | $9.30 | $9.90 | $9.26 | 2,905,600 | |
| $9.24 | +0.11 | +1.2% | $9.12 | $9.25 | $9.004 | 1,514,400 | |
| $9.13 | +0.49 | +5.7% | $8.85 | $9.27 | $8.64 | 5,034,900 | |
| $8.64 | -0.32 | -3.6% | $8.895 | $8.955 | $8.58 | 4,125,000 | |
| $8.96 | -0.31 | -3.3% | $9.17 | $9.305 | $8.93 | 3,426,600 | |
| $9.27 | -0.80 | -7.9% | $10.07 | $10.19 | $9.19 | 3,946,100 | |
| $10.07 | +0.71 | +7.6% | $9.36 | $10.07 | $9.28 | 2,939,900 | |
| $9.36 | +0.02 | +0.2% | $9.41 | $9.45 | $9.045 | 2,646,000 | |
| $9.34 | +0.14 | +1.5% | $9.28 | $9.505 | $9.193 | 3,855,700 | |
| $9.20 | -0.06 | -0.6% | $9.16 | $9.345 | $9.135 | 3,417,700 | |
| $9.26 | +0.13 | +1.4% | $9.17 | $9.43 | $9.025 | 2,936,300 | |
| $9.13 | +0.02 | +0.2% | $9.00 | $9.34 | $8.92 | 2,943,600 | |
| $9.11 | +0.22 | +2.5% | $8.955 | $9.205 | $8.735 | 2,915,600 | |
| $8.89 | +0.25 | +2.9% | $8.52 | $8.925 | $8.52 | 2,314,500 | |
| $8.64 | -0.19 | -2.2% | $8.82 | $9.125 | $8.59 | 2,586,000 | |
| $8.83 | +0.31 | +3.6% | $8.51 | $8.845 | $8.51 | 2,321,000 | |
| $8.52 | +0.10 | +1.2% | $8.49 | $8.64 | $8.425 | 1,894,300 | |
| $8.42 | -0.16 | -1.9% | $8.58 | $8.65 | $8.165 | 6,720,300 | |
| $8.58 | +0.45 | +5.5% | $8.25 | $8.615 | $8.165 | 2,259,900 | |
| $8.13 | -0.27 | -3.2% | $8.34 | $8.405 | $8.04 | 3,914,600 | |
| $8.40 | +0.40 | +5.0% | $7.97 | $8.40 | $7.949 | 2,121,300 | |
| $8.00 | +0.45 | +6.0% | $7.61 | $8.09 | $7.58 | 1,695,800 | |
| $7.55 | +0.13 | +1.8% | $7.51 | $7.57 | $7.39 | 1,486,100 | |
| $7.42 | -0.21 | -2.8% | $7.52 | $7.61 | $7.31 | 2,255,200 | |
| $7.63 | -0.11 | -1.4% | $7.71 | $7.721 | $7.495 | 1,462,900 | |
| $7.74 | -0.20 | -2.5% | $7.80 | $7.84 | $7.605 | 2,879,900 | |
| $7.94 | -0.19 | -2.3% | $8.02 | $8.05 | $7.905 | 1,271,300 | |
| $8.13 | -0.15 | -1.8% | $8.35 | $8.43 | $7.992 | 2,125,100 | |
| $8.28 | +0.18 | +2.2% | $8.10 | $8.415 | $8.10 | 1,525,400 | |
| $8.10 | -0.19 | -2.3% | $8.215 | $8.285 | $8.065 | 2,480,100 | |
| $8.29 | -0.06 | -0.7% | $8.22 | $8.31 | $8.03 | 1,712,500 | |
| $8.35 | -0.06 | -0.7% | $8.38 | $8.48 | $8.315 | 2,060,400 | |
| $8.41 | +0.19 | +2.3% | $8.23 | $8.49 | $8.20 | 1,402,000 | |
| $8.22 | +0.08 | +1.0% | $8.12 | $8.24 | $8.045 | 1,150,200 | |
| $8.14 | +0.18 | +2.3% | $7.99 | $8.265 | $7.955 | 2,558,900 | |
| $7.96 | -0.47 | -5.6% | $8.43 | $8.46 | $7.88 | 2,304,600 | |
| $8.43 | -0.30 | -3.4% | $8.83 | $8.83 | $8.39 | 2,044,500 | |
| $8.73 | +0.37 | +4.4% | $8.405 | $8.885 | $8.36 | 2,704,900 |
- Ticker
- NASDAQ:CERT
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Nov 5, 2026
Certara Reports Third Quarter 2026 Financial Results
Latest earnings call · Nov 5, 2026
Certara (NASDAQ:CERT) Q3 2026 Earnings Call
Replay and transcript
Latest deck · September 2026
Certara Biotech Forum: Developing Investor-Ready Strategies (Boston, 2026)
Conference · 119 slides
Latest news
Certara Reports Third Quarter 2026 Financial Results
Nov 5, 2026
Closed $12.18 (+9.8%) on Nov 5, 2026
Certara to Report Third Quarter 2026 Financial Results on November 5th, 2026
Oct 26, 2026
Closed $10.61 (+2.7%) on Oct 26, 2026
Certara Reports Second Quarter 2026 Financial Results
Aug 4, 2026
Closed $7.80 (-4.6%) on Aug 4, 2026
Certara to Report Second Quarter 2026 Financial Results on August 4th, 2026
Jul 15, 2026
Closed $7.28 (+3.1%) on Jul 16, 2026
Certara Accelerates Drug Discovery and Development with NVIDIA BioNeMo Agent Toolkit
Jul 7, 2026
Closed $7.17 (+0.6%) on Jul 7, 2026
Certara Announces CFO Transition
Jun 17, 2026
Closed $5.54 (-8.1%) on Jun 18, 2026
Certara Reports First Quarter 2026 Financial Results
May 11, 2026
Closed $5.13 (-18.7%) on May 11, 2026
Altasciences and Certara Announce Strategic Partnership to Accelerate Early Drug Development
May 7, 2026
Closed $6.31 (+0.8%) on May 7, 2026
Certara Enters Definitive Agreement for the Sale of its Regulatory and Medical Writing Business to Veristat
Apr 22, 2026
Closed $6.38 (+2.9%) on Apr 22, 2026
Certara to Report First Quarter 2026 Financial Results on May 11th, 2026
Apr 9, 2026
Closed $5.55 (+2.6%) on Apr 10, 2026
Certara, Inc. on 6ix
- News releases
- 14 in the last 12 months · 139 in all · newest Nov 5, 2026 · oldest 2020
- Calls
- 22 calls with a replay · 22 with a transcript · latest Nov 5, 2026
- Decks
- 53 decks · latest September 2026
Where Certara, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:CERT · Home listing · This page | NASDAQ | United States | USD |
| Hamburg:700 | Hamburg | Germany | EUR |
| Tradegate:700 | Tradegate | Germany | EUR |
| LS Exchange:A2QJL8 | LS Exchange | Germany | EUR |
| Lang & Schwarz:A2QJL8 | Lang & Schwarz | Germany | EUR |
| BMV:CERT | BMV | Mexico | MXN |
| BOATS:CERT | BOATS | United States | USD |
| BIVA:CERT | BIVA | Mexico | MXN |
Valuation
Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- $1.69B USD
- P/E
- Loss
- EV/sales
- 4.0×
- EV/EBITDA
- 20.7×
- Price/book
- 1.6×
- Gross margin
- 55.8%
- Operating margin
- 1.0%
- Net margin
- −15.2%
- Debt to equity
- 0.3×
- Beta vs S&P 500
- 0.54
Forecasts
4 strong buy · 9 hold · Analysts' consensus from EODHD, read Nov 15, 2026. Not 6ix's view and not investment advice.
- Price target
- 12.68 USD · Analysts' mean
- EPS, year to Dec 2026
- 0.33 · 13 analysts
- Revenue, year to Dec 2026
- 380.8M · 12 analysts
Team and board
Officers
| Officer | Role |
|---|---|
| Jon Resnick | Chief Executive Officer and Member of the Board |
| Faiz Mohammed | Interim Chief Financial Officer |
| Adrian McKemey | President, Certara Drug Development Solutions |
| Julien Perrier | President, Chief Commercial Officer |
| Martin Snyder | President, Certara Data Sciences |
| Robert Aspbury | President, Certara Predictive Technologies |
| Daniel Corcoran | Senior Vice President and General Counsel |
| Ron DiSantis | SVP of Corporate Development |
| Chris Bouton | Chief Technology Officer, Chief AI Officer |
| Eric Jahn | Chief Information Officer |
| Grant Peterson | Chief Product Officer |
| Rona Anhalt | Chief Human Resources Officer |
Board
| Director | Role |
|---|---|
| James E. Cashman | Chairman of the Board |
| Arjun Bedi | |
| David Spaight | |
| John Reynders | |
| Jon Resnick | Chief Executive Officer and Member of the Board |
| Matthew Walsh | |
| Nancy Killefer | |
| Stephen McLean |
Events
Calls
| Call | When | Status |
|---|---|---|
| Certara (NASDAQ:CERT) Q3 2026 Earnings Call | Thu, Nov 05, 2026 · 8:30 AM ET | Replay |
| Certara (NASDAQ:CERT) Q2 2026 Earnings Call | Tue, Aug 04, 2026 · 8:30 AM ET | Replay |
| Certara (NASDAQ:CERT) Q1 2026 Earnings Call | Mon, May 11, 2026 · 8:30 AM ET | Replay |
| Certara (NASDAQ:CERT) Q4 2025 Earnings Call | Thu, Feb 26, 2026 · 8:30 AM ET | Replay |
| Certara (NASDAQ:CERT) Q3 2025 Earnings Call | Thu, Nov 06, 2025 · 5:00 PM ET | Replay |
| Certara (NASDAQ:CERT) Q2 2025 Earnings Call | Wed, Aug 06, 2025 · 5:00 PM ET | Replay |
| Certara (NASDAQ:CERT) Q1 2025 Earnings Call | Mon, May 05, 2025 · 5:00 PM ET | Replay |
| Certara (NASDAQ:CERT) Q4 2024 Earnings Call | Wed, Feb 26, 2025 · 5:00 PM ET | Replay |
| Certara (NASDAQ:CERT) Q3 2024 Earnings Call | Wed, Nov 06, 2024 · 5:00 PM ET | Replay |
| Certara (NASDAQ:CERT) Q2 2024 Earnings Call | Tue, Aug 06, 2024 · 5:00 PM ET | Replay |
All 22 calls
| Call | When | Status |
|---|---|---|
| Certara (NASDAQ:CERT) Q1 2024 Earnings Call | Tue, May 07, 2024 · 5:00 PM ET | Replay |
| Certara (NASDAQ:CERT) Q4 2023 Earnings Call | Thu, Feb 29, 2024 · 5:00 PM ET | Replay |
| Certara (NASDAQ:CERT) Q3 2023 Earnings Call | Wed, Nov 08, 2023 · 5:00 PM ET | Replay |
| Certara (NASDAQ:CERT) Q2 2023 Earnings Call | Wed, Aug 09, 2023 · 5:00 PM ET | Replay |
| Certara (NASDAQ:CERT) Q1 2023 Earnings Call | Mon, May 08, 2023 · 5:00 PM ET | Replay |
| Certara (NASDAQ:CERT) Q4 2022 Earnings Call | Wed, Mar 01, 2023 · 5:00 PM ET | Replay |
| Certara (NASDAQ:CERT) Q3 2022 Earnings Call | Mon, Nov 07, 2022 · 5:00 PM ET | Replay |
| Certara (NASDAQ:CERT) Q2 2022 Earnings Call | Tue, Aug 09, 2022 · 5:00 PM ET | Replay |
| Certara (NASDAQ:CERT) Q1 2022 Earnings Call | Thu, May 05, 2022 · 5:00 PM ET | Replay |
| Certara (NASDAQ:CERT) Q4 2021 Earnings Call | Thu, May 05, 2022 · 5:00 PM ET | Replay |
| Certara (NASDAQ:CERT) Q3 2021 Earnings Call | Tue, Nov 09, 2021 · 5:00 PM ET | Replay |
| Certara (NASDAQ:CERT) Q1 2021 Earnings Call | Thu, May 06, 2021 · 5:00 PM ET | Replay |
Results days
| Quarter | Results | Share move |
|---|---|---|
| Q3 2026 | Nov 5, 2026 · Before open | +9.8% |
| Q2 2026 | Aug 4, 2026 · Before open | −4.7% |
| Q1 2026 | May 11, 2026 · Before open | −18.7% |
| Q4 2025 | Feb 26, 2026 | +7.4% |
| Q3 2025 | Nov 6, 2025 · After close | −23.1% |
| Q2 2025 | Aug 6, 2025 · After close | +18.1% |
| Q1 2025 | May 5, 2025 · After close | −11.0% |
| Q4 2024 | Feb 26, 2025 · Before open | −0.4% |
| Q3 2024 | Nov 6, 2024 · After close | +0.7% |
| Q2 2024 | Aug 6, 2024 · After close | −13.6% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q1 2024 | May 7, 2024 · After close | −7.4% |
| Q4 2023 | Feb 29, 2024 · After close | +8.4% |
| Q3 2023 | Nov 8, 2023 · After close | +1.4% |
| Q2 2023 | Aug 9, 2023 · After close | −7.7% |
| Q1 2023 | May 8, 2023 · After close | −10.7% |
| Q4 2022 | Mar 1, 2023 · After close | +17.3% |
| Q3 2022 | Nov 7, 2022 · After close | +7.1% |
| Q2 2022 | Aug 9, 2022 · After close | −10.9% |
| Q1 2022 | May 5, 2022 · After close | +2.5% |
| Q4 2021 | Mar 1, 2022 · After close | −11.1% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Certara Biotech Forum: Developing Investor-Ready Strategies (Boston, 2026) | Conference | 119 slides | September 2026 |
| Q2 2026 Earnings Presentation | Earnings | 16 slides | Aug 4, 2026 |
| Q1 2026 Earnings Presentation | Earnings | 18 slides | May 11, 2026 |
| Q4 2025 Earnings Presentation | Earnings | 21 slides | Feb 26, 2026 |
| Q3 2025 Earnings Presentation | Earnings | 23 slides | Nov 6, 2025 |
| Fact Sheet (November 2025) | Fact sheet | 4 slides | November 2025 |
| Blueprint for Biotech Success webinar (September 2025) | Conference | 27 slides | September 2025 |
| Q2 2025 Earnings Presentation | Earnings | 23 slides | Aug 6, 2025 |
| Q1 2025 Earnings Presentation | Earnings | 23 slides | May 5, 2025 |
| Fact Sheet (April 2025) | Fact sheet | 4 slides | April 2025 |
Show 50 decks
This page holds 50 of 53 decks. Open Decks
IPO
Priced at US$23.00 a share on Dec 10, 2020.
- Price
- US$23.00 a share
- Shares offered
- 29,055,000 shares of common stock · 14,630,000 from the company and 14,425,000 from selling shareholders
- Offering size
- US$668.3 million
- Underwriters' option
- Up to 4,358,250 more shares
- Listing
- CERT on the Nasdaq Global Select Market
- Underwriters
- Jefferies, Morgan Stanley, BofA Securities, Credit Suisse, Barclays, William Blair · In the order on the cover
- Shares delivered
- On or about Dec 15, 2020
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Oct 8, 2020 |
| Filed publicly | Nov 18, 2020 |
| Amended twice | Newest Dec 3, 2020 |
| Declared effective by the SEC | Dec 10, 2020 |
| Shares registered with an exchange | Dec 11, 2020 |
| Final prospectus, with the price | Dec 14, 2020 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Dec 14, 2020 |
| CERT · Exchange's certificate of listing | Dec 11, 2020 |
| 8-A12B · Registration of shares for listing on an exchange | Dec 11, 2020 |
| EFFECT · Notice that a registration is effective | Dec 10, 2020 |
| S-1MEF · Registration of more shares for the same offering | Dec 10, 2020 |
| CORRESP · Letter to the SEC | Dec 8, 2020 |
| S-1/A · Registration statement, amended | Dec 3, 2020 |
| CORRESP · Letter to the SEC | Nov 25, 2020 |
| S-1/A · Registration statement, amended | Nov 25, 2020 |
| UPLOAD · Letter from the SEC | Nov 24, 2020 |
All 15 filings
| Filing | Filed |
|---|---|
| S-1 · Registration statement | Nov 18, 2020 |
| DRSLTR · Letter to the SEC with a draft | Nov 10, 2020 |
| DRS/A · Draft registration statement, amended | Nov 10, 2020 |
| UPLOAD · Letter from the SEC | Nov 4, 2020 |
| DRS · Draft registration statement | Oct 8, 2020 |
Open IPO · From the cover of the final prospectus (424B4) filed Dec 14, 2020
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 418.8M | 385.1M | 354.3M | 335.6M | 286.1M | 243.5M | 208.5M | 163.7M |
| Cost of revenue | 161.1M | 154.5M | 141.0M | 132.6M | 111.6M | 100.8M | 79.8M | 71.0M |
| Gross profit | 257.7M | 230.6M | 213.3M | 203.1M | 174.5M | 142.8M | 128.7M | 92.7M |
| Research and development | 41.0M | 37.1M | 34.2M | 28.2M | 20.4M | 19.6M | 11.6M | 10.5M |
| Selling, general and administrative | 85.4M | 73.5M | 95.4M | 71.8M | 79.5M | 88.5M | 47.9M | 43.4M |
| Operating income | 21.0M | -1.73M | -40.8M | 32.5M | 13.6M | -24.4M | 19.6M | -4.65M |
| Depreciation and amortization | 75.2M | 68.0M | 56.1M | 1.73M | 2.13M | 2.44M | 2.60M | 37.0M |
| EBITDA | 96.2M | 66.3M | 15.3M | 34.3M | 15.7M | -22.0M | 22.2M | 32.4M |
| Interest expense | 19.7M | 21.5M | 22.9M | 17.8M | 16.8M | 25.3M | 28.0M | 27.8M |
| Income before tax | 7.62M | -17.2M | -55.1M | 18.8M | -3.38M | -50.2M | -9.15M | -32.6M |
| Income tax | 9.21M | -5.13M | 214.0K | 4.02M | 9.89M | -784.0K | -225.0K | 697.0K |
| Net income | -1.59M | -12.1M | -55.4M | 14.7M | -13.3M | -49.4M | -8.93M | -33.3M |
| Earnings per share, basic | -0.01 | -0.08 | -0.35 | 0.09 | -0.09 | -0.37 | -0.07 | -0.25 |
| Earnings per share, diluted | -0.01 | -0.08 | -0.35 | 0.09 | -0.09 | -0.37 | -0.07 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 189.4M | 179.2M | 235.0M | 236.6M | 185.8M | 271.4M | 29.3M | 11.7M |
| Short-term investments | 4.47M | 4.64M | 57.0K | 1.49M | ||||
| Receivables | 94.6M | 90.6M | 75.4M | 72.2M | 60.2M | 46.4M | 52.4M | 49.9M |
| Inventory | 1 | -4.47M | 3.10M | 827.0K | 1.91M | 4.28M | 5.53M | |
| Current assets | 315.1M | 310.9M | 340.2M | 342.3M | 274.7M | 346.6M | 87.5M | 68.9M |
| Property, plant and equipment | 1.80M | 2.17M | 2.67M | 2.40M | 2.94M | 3.87M | 4.62M | 5.40M |
| Goodwill | 745.1M | 757.0M | 716.3M | 717.7M | 703.4M | 518.6M | 515.0M | 514.3M |
| Total assets | 1.56B | 1.58B | 1.56B | 1.57B | 1.51B | 1.27B | 1.04B | 1.05B |
| Accounts payable | 3.04M | 3.50M | 5.17M | 7.53M | 7.46M | 6.39M | 4.92M | 4.91M |
| Current liabilities | 153.4M | 146.1M | 130.0M | 103.2M | 92.2M | 75.3M | 63.0M | 65.5M |
| Long-term debt | 290.1M | 292.4M | 288.2M | 290.0M | 291.7M | 294.1M | 397.1M | 404.8M |
| Total debt | 293.1M | 295.4M | 291.2M | 293.0M | 294.8M | 298.8M | 401.4M | 408.3M |
| Total liabilities | 493.8M | 516.4M | 516.3M | 493.3M | 469.9M | 447.3M | 545.0M | 558.7M |
| Shareholders' equity | 1.06B | 1.06B | 1.05B | 1.08B | 1.04B | 822.1M | 492.0M | 492.8M |
| Shares outstanding | 159.1M | 161.0M | 159.8M | 159.5M | 159.7M | 153.0M | 159.5M | 132.4M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 96.3M | 80.5M | 82.8M | 92.5M | 60.4M | 44.8M | 38.0M | 11.6M |
| Capital spending | -1.76M | -1.63M | -1.78M | -1.43M | -1.14M | -863.0K | -2.11M | -11.5M |
| Free cash flow | 94.6M | 78.8M | 81.0M | 91.1M | 59.2M | 43.9M | 35.9M | 107.0K |
| Cash from investing | -26.6M | -112.4M | -79.5M | -27.8M | -269.9M | -8.61M | -9.52M | -73.9M |
| Cash from financing | -64.0M | -21.0M | -9.45M | -7.36M | 123.4M | 208.2M | -8.49M | 57.3M |
| Dividends paid | -272.0K | -19.9M | -703.0K | -75.0M | ||||
| Share buybacks | -42.6M | 0 | 0 | -2.96M | -272.0K | -1.08M | -703.0K | -1.10M |
| Change in cash | 10.2M | -55.8M | -4.74M | 53.1M | -86.7M | 243.5M | 17.6M | -6.35M |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 4 · Change in ownership | Nov 19, 2026 | Insider trade | SEC |
| 10-Q · Quarterly report | Nov 5, 2026 | Quarterly report | SEC |
| 8-K · Current report | Nov 5, 2026 | Results | SEC |
| 144 · Notice of proposed sale | Sep 3, 2026 | Other filings | SEC |
| 4 · Change in ownership | Sep 2, 2026 | Insider trade | SEC |
| 8-K · Current report | Aug 7, 2026 | Current report | SEC |
| 10-Q · Quarterly report | Aug 4, 2026 | Quarterly report | SEC |
| 8-K · Current report | Aug 4, 2026 | Results | SEC |
| 8-K · Current report | Aug 4, 2026 | Management or board change | SEC |
| 3 · Initial statement of ownership | Jul 17, 2026 | Insider trade | SEC |
Show 200 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| SCHEDULE 13G/A · Big-stake notice, amended | Jul 14, 2026 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Jul 8, 2026 | Big-stake notice | SEC |
| 8-K · Current report | Jun 17, 2026 | Management or board change | SEC |
| 4 · Change in ownership | Jun 2, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 2, 2026 | Insider trade | SEC |
| 8-K · Current report | May 15, 2026 | Meeting outcome | SEC |
| 4 · Change in ownership | May 15, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 13, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 13, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 13, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 13, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 13, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 13, 2026 | Insider trade | SEC |
| 10-Q · Quarterly report | May 11, 2026 | Quarterly report | SEC |
| 8-K · Current report | May 11, 2026 | Results | SEC |
| D | Apr 28, 2026 | Other filings | SEC |
| 8-K · Current report | Apr 22, 2026 | Material contract | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Apr 6, 2026 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Apr 6, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Apr 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Apr 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Apr 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Apr 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Apr 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Apr 3, 2026 | Insider trade | SEC |
| ARS · Annual report to shareholders | Apr 3, 2026 | Annual report | SEC |
| DEFA14A · Additional proxy material | Apr 3, 2026 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Apr 3, 2026 | Meeting notice | SEC |
| 8-K · Current report | Mar 31, 2026 | Management or board change | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Mar 26, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Mar 2, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Mar 2, 2026 | Insider trade | SEC |
| 10-K · Annual report | Feb 26, 2026 | Annual report | SEC |
| 8-K · Current report | Feb 26, 2026 | Results | SEC |
| 3 · Initial statement of ownership | Jan 12, 2026 | Insider trade | SEC |
| 8-K · Current report | Dec 11, 2025 | Management or board change | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Nov 25, 2025 | Big-stake notice | SEC |
| SCHEDULE 13G · Big-stake notice | Nov 13, 2025 | Big-stake notice | SEC |
| 4 · Change in ownership | Nov 12, 2025 | Insider trade | SEC |
| 10-Q · Quarterly report | Nov 6, 2025 | Quarterly report | SEC |
| 8-K · Current report | Nov 6, 2025 | Results | SEC |
| 8-K · Current report | Oct 16, 2025 | Material contract | SEC |
| SCHEDULE 13G · Big-stake notice | Oct 9, 2025 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Oct 7, 2025 | Big-stake notice | SEC |
| 4 · Change in ownership | Sep 11, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Sep 9, 2025 | Other filings | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Aug 13, 2025 | Big-stake notice | SEC |
| 10-Q · Quarterly report | Aug 6, 2025 | Quarterly report | SEC |
| 8-K · Current report | Aug 6, 2025 | Results | SEC |
| 4 · Change in ownership | Jun 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 22, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 22, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 22, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 22, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 22, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 22, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 22, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 22, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 22, 2025 | Insider trade | SEC |
| 8-K · Current report | May 22, 2025 | Meeting outcome | SEC |
| 4 · Change in ownership | May 22, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 22, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 22, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 22, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 22, 2025 | Insider trade | SEC |
| 10-Q · Quarterly report | May 5, 2025 | Quarterly report | SEC |
| 8-K · Current report | May 5, 2025 | Results | SEC |
| SCHEDULE 13D/A · Big-stake notice, amended | Apr 14, 2025 | Big-stake notice | SEC |
| 8-K · Current report | Apr 14, 2025 | Results | SEC |
| ARS · Annual report to shareholders | Apr 8, 2025 | Annual report | SEC |
| DEFA14A · Additional proxy material | Apr 8, 2025 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Apr 8, 2025 | Meeting notice | SEC |
| 4 · Change in ownership | Apr 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Apr 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Apr 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Apr 3, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Apr 2, 2025 | Other filings | SEC |
| D | Mar 28, 2025 | Other filings | SEC |
| 3 · Initial statement of ownership | Mar 10, 2025 | Insider trade | SEC |
| 8-K · Current report | Mar 5, 2025 | Management or board change | SEC |
| 10-K · Annual report | Feb 26, 2025 | Annual report | SEC |
| 8-K · Current report | Feb 26, 2025 | Results | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Feb 13, 2025 | Big-stake notice | SEC |
| 8-K · Current report | Jan 15, 2025 | Results | SEC |
| UPLOAD · Letter from the SEC | Dec 20, 2024 | Other filings | SEC |
| 10-K/A · Annual report, amended | Dec 16, 2024 | Annual report | SEC |
| CORRESP · Letter to the SEC | Dec 16, 2024 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Dec 5, 2024 | Other filings | SEC |
| SC 13G · Big-stake notice | Nov 14, 2024 | Big-stake notice | SEC |
| 10-Q · Quarterly report | Nov 6, 2024 | Quarterly report | SEC |
| 8-K · Current report | Nov 6, 2024 | Results | SEC |
| 4 · Change in ownership | Oct 18, 2024 | Insider trade | SEC |
| 3 · Initial statement of ownership | Oct 18, 2024 | Insider trade | SEC |
| 8-K · Current report | Oct 16, 2024 | Management or board change | SEC |
| 4 · Change in ownership | Oct 8, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Oct 7, 2024 | Insider trade | SEC |
| 144 · Notice of proposed sale | Oct 7, 2024 | Other filings | SEC |
| SC 13G/A · Big-stake notice, amended | Oct 4, 2024 | Big-stake notice | SEC |
| 4 · Change in ownership | Sep 10, 2024 | Insider trade | SEC |
| 144 · Notice of proposed sale | Sep 9, 2024 | Other filings | SEC |
| 10-Q · Quarterly report | Aug 6, 2024 | Quarterly report | SEC |
| 8-K · Current report | Aug 6, 2024 | Results | SEC |
| 8-K · Current report | Jul 19, 2024 | Current report | SEC |
| 8-K · Current report | Jul 9, 2024 | Current report | SEC |
| 4 · Change in ownership | Jul 2, 2024 | Insider trade | SEC |
| 8-K · Current report | Jun 26, 2024 | Material contract | SEC |
| 4 · Change in ownership | Jun 3, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jun 3, 2024 | Insider trade | SEC |
| 3 · Initial statement of ownership | May 30, 2024 | Insider trade | SEC |
| 3 · Initial statement of ownership | May 30, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 23, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 23, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 23, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 23, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 23, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 23, 2024 | Insider trade | SEC |
| 8-K · Current report | May 23, 2024 | Meeting outcome | SEC |
| 10-Q · Quarterly report | May 7, 2024 | Quarterly report | SEC |
| 8-K · Current report | May 7, 2024 | Results | SEC |
| DEFA14A · Additional proxy material | Apr 12, 2024 | Meeting notice | SEC |
| ARS · Annual report to shareholders | Apr 10, 2024 | Annual report | SEC |
| DEFA14A · Additional proxy material | Apr 10, 2024 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Apr 10, 2024 | Meeting notice | SEC |
| 4/A · Change in ownership, amended | Apr 5, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Apr 4, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Apr 3, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Apr 3, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Apr 3, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Apr 3, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Apr 3, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Apr 3, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Apr 3, 2024 | Insider trade | SEC |
| 144 · Notice of proposed sale | Apr 2, 2024 | Other filings | SEC |
| 144 · Notice of proposed sale | Apr 1, 2024 | Other filings | SEC |
| PRE 14A · Preliminary proxy statement | Mar 29, 2024 | Meeting notice | SEC |
| D | Mar 27, 2024 | Other filings | SEC |
| 4 · Change in ownership | Mar 6, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Mar 6, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Mar 6, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Mar 6, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Mar 6, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Mar 5, 2024 | Insider trade | SEC |
| 144 · Notice of proposed sale | Mar 4, 2024 | Other filings | SEC |
| 10-K · Annual report | Feb 29, 2024 | Annual report | SEC |
| 8-K · Current report | Feb 29, 2024 | Results | SEC |
| 4 · Change in ownership | Feb 21, 2024 | Insider trade | SEC |
| 144 · Notice of proposed sale | Feb 20, 2024 | Other filings | SEC |
| 4 · Change in ownership | Feb 14, 2024 | Insider trade | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 13, 2024 | Big-stake notice | SEC |
| 144 · Notice of proposed sale | Feb 12, 2024 | Other filings | SEC |
| SC 13G/A · Big-stake notice, amended | Jan 30, 2024 | Big-stake notice | SEC |
| SC 13G · Big-stake notice | Jan 25, 2024 | Big-stake notice | SEC |
| 4 · Change in ownership | Dec 27, 2023 | Insider trade | SEC |
| 144 · Notice of proposed sale | Dec 26, 2023 | Other filings | SEC |
| 10-Q · Quarterly report | Nov 8, 2023 | Quarterly report | SEC |
| 8-K · Current report | Nov 8, 2023 | Results | SEC |
| 4 · Change in ownership | Oct 6, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Sep 12, 2023 | Insider trade | SEC |
| 144 · Notice of proposed sale | Sep 11, 2023 | Other filings | SEC |
| 4 · Change in ownership | Aug 23, 2023 | Insider trade | SEC |
| 10-Q · Quarterly report | Aug 9, 2023 | Quarterly report | SEC |
| 8-K · Current report | Aug 9, 2023 | Results | SEC |
| 4 · Change in ownership | Aug 2, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jul 3, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jun 6, 2023 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jun 5, 2023 | Other filings | SEC |
| 8-K · Current report | May 25, 2023 | Meeting outcome | SEC |
| 4 · Change in ownership | May 25, 2023 | Insider trade | SEC |
| 4 · Change in ownership | May 25, 2023 | Insider trade | SEC |
| 4 · Change in ownership | May 25, 2023 | Insider trade | SEC |
| 4 · Change in ownership | May 25, 2023 | Insider trade | SEC |
| 4 · Change in ownership | May 25, 2023 | Insider trade | SEC |
| 4 · Change in ownership | May 25, 2023 | Insider trade | SEC |
| 4 · Change in ownership | May 19, 2023 | Insider trade | SEC |
| 4 · Change in ownership | May 19, 2023 | Insider trade | SEC |
| 4 · Change in ownership | May 18, 2023 | Insider trade | SEC |
| 4 · Change in ownership | May 18, 2023 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2023 | Insider trade | SEC |
| 144 · Notice of proposed sale | May 11, 2023 | Other filings | SEC |
| 10-Q · Quarterly report | May 8, 2023 | Quarterly report | SEC |
| 8-K · Current report | May 8, 2023 | Results | SEC |
| 4 · Change in ownership | Apr 17, 2023 | Insider trade | SEC |
This page holds 200 of 467 filings. Open Filings
Cap table
Built by 6ix from Certara, Inc.’s releases · as of Nov 1, 2026
- Common shares
- 152,543,402
- Fully diluted
- 152,543,402
Fully diluted
| Line | Shares | As of |
|---|---|---|
| Common shares | 152,543,402 | Nov 1, 2026 |
Share count over time
| Count | Shares |
|---|---|
| Nov 1, 2026 | 152,543,402 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Carol G. Gallagher Other companies: TRex Bio, Inc. (Lead Independent Director · Since at least Nov 5, 2026); PMV Pharmaceuticals, Inc. (Director · Since at least Nov 3, 2022); Atara Biotherapeutics, Inc. (Director · Since at least Jun 27, 2019); Frazier Lifesciences Acquisition Corp (Director · Dec 8, 2020 – Nov 22, 2022 · Past); Metacrine Inc (Director · Sep 15, 2020 – Sep 15, 2020 · Past); Annexon, Inc. (Director · Jul 23, 2020 – Jul 23, 2020 · Past); Turning Point Therapeutics Inc (Director · Jul 24, 2019 – Aug 17, 2022 · Past); Tempest Therapeutics, Inc. (Director · Jun 20, 2019 – Jun 22, 2020 · Past) | Director · Jun 15, 2021 – Jun 15, 2021 · Past |
| Nancy Killefer Other companies: Meta Platforms, Inc. (Director · Since at least Mar 9, 2020); Cardinal Health, Inc. (Director · Since at least Nov 8, 2017); Taubman Centers Inc (Director · Jan 16, 2019 – Dec 29, 2020 · Past); Avon Products Inc (Director · May 16, 2018 – May 16, 2019 · Past); CSRA Inc (Director · Feb 26, 2018 – Apr 3, 2018 · Past); The Advisory Board Company (Director · Nov 17, 2017 – Nov 17, 2017 · Past) | Director · Since at least Aug 1, 2021 |
| Rosemary A. Crane Other companies: Teva Pharmaceutical Industries Limited (Independent Director · Since at least Jan 1, 2018); Tarsus Pharmaceuticals, Inc. (Director · Aug 11, 2021 – Jun 24, 2024 · Past); Catalent Inc (Director · Feb 16, 2018 – Oct 27, 2023 · Past); PDS Biotechnology Corporation (Director · Sep 18, 2017 – Mar 15, 2019 · Past); Unilife Corp (Director · Oct 28, 2016 – Oct 28, 2016 · Past) | Director · Since at least Jul 21, 2022 |
| Sherilyn McCoy Other companies: Kimberly-Clark Corporation (Director · Since at least Sep 12, 2018); Stryker Corporation (Lead Independent Director · Since at least May 2, 2018); NovoCure Limited (Director · May 31, 2018 – Jun 9, 2021 · Past); Avon Products Inc (CEO, Director · Apr 23, 2012 – Apr 23, 2017 · Past); Johnson & Johnson (Member, Executive Committee · Jan 2, 2008 – Feb 9, 2012 · Past) | Director · Dec 11, 2020 – May 18, 2021 · Past |
| Cynthia Collins Other companies: MaxCyte, Inc. (Director · Since at least Jun 18, 2025); Codexis, Inc. (Director · Since at least Mar 28, 2025) | Director · Since at least May 21, 2025 |
| Eric C Liu Other companies: Waystar Holding Corp. (Director · Jun 7, 2024 – Jun 7, 2024 · Past) | Director · Dec 11, 2020 – Dec 11, 2020 · Past |
| James E Cashman III Other companies: National Instruments Corporation (Director · Apr 20, 2022 – Oct 11, 2023 · Past) | Director · Since at least May 17, 2022 |
| William F Feehery Other companies: West Pharmaceutical Services, Inc. (Director · Since at least Feb 21, 2012) | CHIEF EXECUTIVE OFFICER, Director · Since at least Dec 11, 2020 |
| Adrian McKemey | President, Certara Drug Development Solutions · Since at least Mar 5, 2025 |
| Arjun Bedi | Director · Since at least Feb 24, 2026 |
All 33 people
| Person | Seat |
|---|---|
| Chris Bouton | Chief Technology Officer, Chief AI Officer · Since at least Jul 7, 2026 |
| Daniel Corcoran | Senior Vice President and General Counsel · Since at least Jun 2, 2026 |
| David Spaight | Director · Since at least Nov 5, 2026 |
| Drayton Virkler | PRESIDENT, REG & ACCES · Sep 2, 2022 – Mar 31, 2023 · Past |
| Eran Broshy | Director · Since at least May 14, 2026 |
| Eric Jahn | Chief Information Officer · Since at least Nov 5, 2026 |
| Faiz Mohammed | Interim Chief Financial Officer · Since at least Aug 4, 2026 |
| Grant Peterson | Chief Product Officer · Since at least Nov 5, 2026 |
| James E. Cashman | Chairman of the Board · Since at least Dec 11, 2025 |
| Jieun W Choe | CHIEF STRATEGY & MARKETING · Dec 11, 2020 – Apr 1, 2022 · Past |
| John Reynders | Chief Financial Officer, Director · Since at least May 14, 2026 |
| Jon Resnick | Chief Executive Officer and Member of the Board · Since at least May 13, 2026 |
| Julien Perrier | President, Chief Commercial Officer · Since at least Aug 4, 2026 |
| Justin Edge | PRES., REGULATORY & ACCESS · Dec 11, 2020 – Apr 1, 2022 · Past |
| Leif E Pedersen | PRESIDENT, CHIEF COMMERCAL OFF · Since at least Apr 1, 2026 |
| Martin Snyder | President, Certara Data Sciences · Since at least Nov 4, 2025 |
| Matthew Walsh | Director · Since at least May 15, 2026 |
| Nicolette D Sherman | CHIEF HUMAN RESOURCES OFFICER · Jul 16, 2021 – Apr 1, 2024 · Past |
| Patrick F Smith | PRESIDENT, DRUG DEV SOLUTIONS · Nov 1, 2021 – Oct 7, 2024 · Past |
| Robert Aspbury | President, Certara Predictive Technologies · Since at least Apr 1, 2022 |
| Rona Anhalt | Chief Human Resources Officer · Since at least May 23, 2024 |
| Ron DiSantis | SVP of Corporate Development · Since at least Nov 4, 2026 |
| Stephen McLean | Director · Since at least Nov 5, 2026 |
Log in to ask 6ix AI your own questions about Certara, Inc.